SLC29A1 and non-small cell lung carcinoma: Responses to gemcitabine-based chemotherapy were evident in patients with high hENT1 expression but not in patients without hENT1 expression in an analysis of 24 patients with non-small cell lung cancer (Oguri et al., 2007).